Identification and characterisation of novel antimicrobials against Mycobacterium tuberculosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Lübeck, Universität zu Lübeck, Dissertation, 2024
- Keyword
-
Antimikrobieller Wirkstoff
Arzneimittelentwicklung
- Event
-
Veröffentlichung
- (where)
-
Lübeck
- (who)
-
Zentrale Hochschulbibliothek Lübeck
- (when)
-
2024
- Creator
-
Sonawane, Vidhisha Vijay
- Contributor
-
Reiling, Norbert
- URN
-
urn:nbn:de:gbv:841-2024112939
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sonawane, Vidhisha Vijay
- Reiling, Norbert
- Zentrale Hochschulbibliothek Lübeck
Time of origin
- 2024
Other Objects (12)
Human recombinant antibodies against Mycobacterium tuberculosis antigens
Human recombinant antibodies against Mycobacterium tuberculosis antigens
Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis
Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis
Antibodies against native proteins of Mycobacterium tuberculosis can detect pulmonary tuberculosis patients
Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv)
Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis
Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
Functional characterization of new antimicrobial lead structures against Mycobacterium tuberculosis
Identification of gene targets against dormant phase Mycobacterium tuberculosis infections
Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis
Tab. 48 Mycobacterium tuberculosis
Human recombinant antibodies against Mycobacterium tuberculosis antigens
Human recombinant antibodies against Mycobacterium tuberculosis antigens
Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis
Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis
Antibodies against native proteins of Mycobacterium tuberculosis can detect pulmonary tuberculosis patients
Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv)
Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis
Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
Functional characterization of new antimicrobial lead structures against Mycobacterium tuberculosis
Identification of gene targets against dormant phase Mycobacterium tuberculosis infections
Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis
Tab. 48 Mycobacterium tuberculosis
Human recombinant antibodies against Mycobacterium tuberculosis antigens
Human recombinant antibodies against Mycobacterium tuberculosis antigens
Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis
Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis
Antibodies against native proteins of Mycobacterium tuberculosis can detect pulmonary tuberculosis patients
Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv)
Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis
Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
Functional characterization of new antimicrobial lead structures against Mycobacterium tuberculosis
Identification of gene targets against dormant phase Mycobacterium tuberculosis infections
Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis